跳至主要内容
临床试验/JPRN-UMIN000013585
JPRN-UMIN000013585已完成未知

Prospective study on anti-islet autoantibody and glucose tolerance in chronic hepatitis C patients treated with interferon. - Anti-islet autoantibody and glucose tolerance in chronic hepatitis C patients treated with interferon.

Department of Gastroenterology and Hepatology, Okayama University Hospital0 个研究点目标入组 78 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with the followings: other viral infections such as infection with the hepatitis B virus or human immunodeficiency virus; any other cause of liver disease, e.g., autoimmune hepatitis, primary biliary cirrhosis, drug-induced liver disease, and excessive daily intake of alcohol (>40 g per day over the period of more than 5 years); relevant disorders, including decompensated liver disease, cirrhosis, hepatocellular carcinoma, and other malignant neoplastic diseases; concomitant use of immunosuppressive or herbal medications (e.g. Sho-saiko-to); current use of intravenous drugs; poorly controlled diabetes mellitus, hypertension, cardiovascular disease, chronic renal failure, or creatinine clearance values <50 mL/min.

研究者

发起方
Department of Gastroenterology and Hepatology, Okayama University Hospital

相似试验